Literature DB >> 19393194

Anti-topoisomerase I autoantibodies in systemic sclerosis.

Tamás Czömpöly1, Diána Simon, László Czirják, Péter Németh.   

Abstract

Systemic sclerosis (SSc) is an autoimmune disease characterized by fibrosis of the skin, vascular abnormalities and activation of the immune system. The majority of SSc patients have autoantibodies against nuclear antigens. Among these antibodies against topoisomerase I (topo I) are frequently detected in sera of SSc patients. Since the discovery of these antibodies as immunoglobulins reacting with a 70 kDa nuclear protein (Scl-70), a massive body of clinical and experimental data has been generated. In this review we summarize accumulated evidence about anti-topo I autoantibodies in SSc, including results of epitope mapping studies and investigations on the possible pathogenic role of these antibodies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19393194     DOI: 10.1016/j.autrev.2009.02.018

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  7 in total

Review 1.  Biomarkers in systemic sclerosis.

Authors:  Susan V Castro; Sergio A Jimenez
Journal:  Biomark Med       Date:  2010-02       Impact factor: 2.851

2.  Advantages of multiplex proteomics in clinical immunology: the case of rheumatoid arthritis: novel IgXPLEX™: planar microarray diagnosis.

Authors:  Peter Lea; Edward Keystone; Sasi Mudumba; Anthony Kahama; Shi-Fa Ding; Jennifer Hansen; Azar A Azad; Sihe Wang; Deborah Weber
Journal:  Clin Rev Allergy Immunol       Date:  2011-08       Impact factor: 8.667

Review 3.  Adipose-Derived Mesenchymal Stem Cells in Autoimmune Disorders: State of the Art and Perspectives for Systemic Sclerosis.

Authors:  Alexandre T J Maria; Marie Maumus; Alain Le Quellec; Christian Jorgensen; Danièle Noël; Philippe Guilpain
Journal:  Clin Rev Allergy Immunol       Date:  2017-04       Impact factor: 8.667

4.  Capillaroscopy as an Outcome Measure for Clinical Trials on the Peripheral Vasculopathy in SSc-Is It Useful?

Authors:  Maurizio Cutolo; Alberto Sulli; Carmen Pizzorni; Vanessa Smith
Journal:  Int J Rheumatol       Date:  2010-08-16

Review 5.  Classical Disease-Specific Autoantibodies in Systemic Sclerosis: Clinical Features, Gene Susceptibility, and Disease Stratification.

Authors:  Changyi Yang; Shunli Tang; Dingxian Zhu; Yingguo Ding; Jianjun Qiao
Journal:  Front Med (Lausanne)       Date:  2020-11-19

6.  Increased Frequency of Activated Switched Memory B Cells and Its Association With the Presence of Pulmonary Fibrosis in Diffuse Cutaneous Systemic Sclerosis Patients.

Authors:  Diána Simon; Péter Balogh; Szabina Erdő-Bonyár; Katalin Böröcz; Tünde Minier; László Czirják; Tímea Berki
Journal:  Front Immunol       Date:  2021-06-30       Impact factor: 7.561

7.  Immunological and Clinical Characteristics of Systemic Lupus Erythematosus: A Series from Morocco.

Authors:  Zeineb Zian; Mouna Maamar; Mohamed El Aouni; Amina Barakat; Rajae El Aouad; Naima Arji; Mohcine Bennani Mechita
Journal:  Biomed Res Int       Date:  2018-09-30       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.